F · Healthcare

LABIANA HEALTH S.A.EO-10 (8RK)

Drug Manufacturers - Specialty & Generic

LABIANA HEALTH S.A.EO-10 (8RK) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 8RK

P/E ratio
18.00

LABIANA HEALTH S.A.EO-10 (8RK) — FAQ

What is 8RK's P/E ratio?

The price-to-earnings (P/E) ratio for LABIANA HEALTH S.A.EO-10 (8RK) is 18.00 (data as of 2026-05-23).

Does LABIANA HEALTH S.A.EO-10 pay a dividend?

Dividend yield is not available in the current snapshot for LABIANA HEALTH S.A.EO-10 (8RK). Check the MyAverix Finance app for the latest dividend data.

What sector is LABIANA HEALTH S.A.EO-10 in?

LABIANA HEALTH S.A.EO-10 (8RK) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 8RK listed on?

8RK is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play